NCT01587339View on ClinicalTrials.gov

Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

CompletedOBSERVATIONAL

Enrollment

6,498

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

July 31, 2011

Conditions

Epilepsy

Interventions

DRUG

retigabine/ezogabine

oral - all doses

DRUG

lacosamide

oral - all doses

DRUG

zonisamide

oral - all doses

DRUG

pregabalin

oral - all doses

DRUG

eslicarbazepine

oral - all doses

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01587339 - Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy | Biotech Hunter | Biotech Hunter